{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:13:04Z","timestamp":1791648784557,"version":"4.3.4"},"reference-count":90,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,9,8]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Epidemiological information is essential in providing appropriate empiric antimicrobial therapy for pneumonia. This study aimed to clarify the epidemiology of community-acquired pneumonia (CAP) by conducting a systematic review of published studies in Japan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data source<\/jats:title>\n                  <jats:p>PubMed and Ichushi web database (January 1970 to October 2022).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Eligibility criteria<\/jats:title>\n                  <jats:p>Clinical studies describing pathogenic micro-organisms in CAP written in English or Japanese, excluding studies on pneumonia other than adult CAP, investigations limited to specific pathogens and case reports.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data extraction and synthesis<\/jats:title>\n                  <jats:p>Patient setting (inpatient vs outpatient), number of patients, concordance with the CAP guidelines, diagnostic criteria and methods for diagnosing pneumonia pathogens as well as the numbers of each isolate. A meta-analysis of various situations was performed to measure the frequency of each aetiological agent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty-six studies were included and 17\u2009095 cases of CAP were identified. Pathogens were undetectable in 44.1% (95% CI 39.7% to 48.5%). <jats:italic>Streptococcus pneumoniae<\/jats:italic> was the most common cause of CAP requiring hospitalisation or outpatient care (20.0% (95% CI 17.2% to 22.8%)), followed by <jats:italic>Haemophilus influenzae<\/jats:italic> (10.8% (95% CI 7.3% to 14.3%)) and <jats:italic>Mycoplasma pneumoniae<\/jats:italic> (7.5% (95% CI 4.6% to 10.4%)). However, when limited to CAP requiring hospitalisation, <jats:italic>Staphylococcus aureus<\/jats:italic> was the third most common at 4.9% (95% CI 3.9% to 5.8%). <jats:italic>Pseudomonas aeruginosa<\/jats:italic> was more frequent in hospitalised cases, while atypical pathogens were less common. Methicillin-resistant <jats:italic>S. aureus<\/jats:italic> accounted for 40.7% (95% CI 29.0% to 52.4%) of <jats:italic>S. aureus<\/jats:italic> cases. In studies that used PCR testing for pan-respiratory viral pathogens, human enterovirus\/human rhinovirus (9.4% (95% CI 0% to 20.5%)) and several other respiratory pathogenic viruses were detected. The epidemiology varied depending on the methodology and situation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The epidemiology of CAP varies depending on the situation, such as in the hospital versus outpatient setting. Viruses are more frequently detected by exhaustive genetic searches, resulting in a significant variation in epidemiology.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-001800","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T13:06:49Z","timestamp":1695733609000},"page":"e001800","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-2167","authenticated-orcid":false,"given":"Yuji","family":"Fujikura","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan"},{"name":"Department of Medical Risk Management and Infection Control, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Somekawa","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshie","family":"Manabe","sequence":"additional","affiliation":[{"name":"Graduate School of Medical Science, Nagoya City University, Nagoya, Aichi, Japan"},{"name":"West Medical Center, Nagoya City University, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Horita","sequence":"additional","affiliation":[{"name":"Chemotherapy Center, Yokohama City University Hospital, Yokohama, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saka General Hospital, Shiogama, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Higa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, National Hospital Organization Okinawa National Hospital, Ginowan, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-4432","authenticated-orcid":false,"given":"Kazuhiro","family":"Yatera","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Miyashita","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Hirakata, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Medical Education Development Center, Nagasaki University Hospital, Nagasaki, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kawana","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"2025083110043994000_10.1.e001800.1","doi-asserted-by":"publisher","DOI":"10.1086\/511159"},{"key":"2025083110043994000_10.1.e001800.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15021-0"},{"key":"2025083110043994000_10.1.e001800.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1312885"},{"key":"2025083110043994000_10.1.e001800.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.2.462"},{"key":"2025083110043994000_10.1.e001800.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.1.9907023"},{"key":"2025083110043994000_10.1.e001800.6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.5.502"},{"key":"2025083110043994000_10.1.e001800.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"2025083110043994000_10.1.e001800.8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/CCM.0000000000005498","article-title":"Etiology, treatments, and outcomes of patients with severe community-acquired pneumonia in a large U.S. sample","volume":"50","author":"Haessler","year":"2022","journal-title":"Crit Care Med"},{"key":"2025083110043994000_10.1.e001800.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"2025083110043994000_10.1.e001800.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2025083110043994000_10.1.e001800.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-644ST"},{"key":"2025083110043994000_10.1.e001800.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2012.11.001"},{"key":"2025083110043994000_10.1.e001800.13","first-page":"S79","article-title":"Guidelines for the management of community acquired pneumonia in adults","volume":"11 Suppl 3","year":"2006","journal-title":"Respirology"},{"key":"2025083110043994000_10.1.e001800.14","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199009000-00004"},{"key":"2025083110043994000_10.1.e001800.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2007.01230.x"},{"key":"2025083110043994000_10.1.e001800.16","doi-asserted-by":"publisher","DOI":"10.2307\/2685469"},{"key":"2025083110043994000_10.1.e001800.17","first-page":"2791","article-title":"Clinical evaluation of community-acquired pneumonia in recent 3 years","volume":"72","author":"Tagagi","year":"1995","journal-title":"Rinsyo-to-Kenkyu"},{"key":"2025083110043994000_10.1.e001800.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.6.1588"},{"key":"2025083110043994000_10.1.e001800.19","first-page":"267","article-title":"[Clinical features and etiology of community-acquired pneumonia at a general hospital between 1994 and 1997]","volume":"38","author":"Motomura","year":"2000","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2025083110043994000_10.1.e001800.20","first-page":"509","article-title":"Mortality and prognostic factors in patients with community-acquired pneumonia: an analysis of 231 cases","volume":"38","author":"Watari","year":"2000","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2025083110043994000_10.1.e001800.21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.11150\/kansenshogakuzasshi1970.75.193","article-title":"Clinical analysis of patients with community-acquired pneumonia requiring hospitalization classified by age group (in Japanese)","volume":"75","author":"Kobashi","year":"2001","journal-title":"Kansenshogakuzasshi"},{"key":"2025083110043994000_10.1.e001800.22","first-page":"558","article-title":"Usefulness of sputum gram staining in community-acquired pneumonia","volume":"40","author":"Sato","year":"2002","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2025083110043994000_10.1.e001800.23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10156-003-0233-Y","article-title":"Clinical effect of ampicillin with beta-Lactamase inhibitor (Sulbactam\/Ampicillin) on community-acquired pneumonia in the elderly","volume":"9","author":"Okimoto","year":"2003","journal-title":"J Infect Chemother"},{"key":"2025083110043994000_10.1.e001800.24","first-page":"261","article-title":"The efficacy of switch therapy in community-acquired pneumonia in Japan","volume":"41","author":"Uchiyama","year":"2003","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2025083110043994000_10.1.e001800.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-004-0350-2"},{"key":"2025083110043994000_10.1.e001800.26","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45920-0"},{"key":"2025083110043994000_10.1.e001800.27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1440-1843.2005.00664.x","article-title":"Usefulness of the Japanese respiratory society guidelines for community pneumonia: a retrospective analysis of community-acquired pneumonia between 2000 and 2002 in a general hospital","volume":"10","author":"Motomura","year":"2005","journal-title":"Respirology"},{"key":"2025083110043994000_10.1.e001800.28","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.710"},{"key":"2025083110043994000_10.1.e001800.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-005-0425-8"},{"key":"2025083110043994000_10.1.e001800.30","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1717"},{"key":"2025083110043994000_10.1.e001800.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-007-0512-0"},{"key":"2025083110043994000_10.1.e001800.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2008.01.014"},{"key":"2025083110043994000_10.1.e001800.33","first-page":"981","article-title":"Evaluation of the severity of community-acquired pneumonia based on the JRS and IDSA\/ATS guidelines","volume":"46","author":"Tashiro","year":"2008","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2025083110043994000_10.1.e001800.34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1357"},{"key":"2025083110043994000_10.1.e001800.35","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1482"},{"key":"2025083110043994000_10.1.e001800.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.12.008"},{"key":"2025083110043994000_10.1.e001800.37","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4651"},{"key":"2025083110043994000_10.1.e001800.38","doi-asserted-by":"publisher","DOI":"10.4104\/pcrj.2011.00067"},{"key":"2025083110043994000_10.1.e001800.39","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-010-0127-8"},{"key":"2025083110043994000_10.1.e001800.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.01983.x"},{"key":"2025083110043994000_10.1.e001800.41","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-011-0282-6"},{"key":"2025083110043994000_10.1.e001800.42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1447-0594.2011.00765.x","article-title":"Factors influencing Weaning from mwechanical ventilation in elderly patients with severe pneumonia","volume":"12","author":"Fujii","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"2025083110043994000_10.1.e001800.43","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31821d33ef"},{"key":"2025083110043994000_10.1.e001800.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.02101.x"},{"key":"2025083110043994000_10.1.e001800.45","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6475"},{"key":"2025083110043994000_10.1.e001800.46","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-011-0344-9"},{"key":"2025083110043994000_10.1.e001800.47","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.8830"},{"key":"2025083110043994000_10.1.e001800.48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1874306401307010060","article-title":"Impact of blood cultures on the changes of treatment in hospitalized patients with community-acquired pneumonia","volume":"7","author":"Ishikawa","year":"2013","journal-title":"Open Respir Med J"},{"key":"2025083110043994000_10.1.e001800.49","doi-asserted-by":"publisher","DOI":"10.1159\/000335466"},{"key":"2025083110043994000_10.1.e001800.50","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit571"},{"key":"2025083110043994000_10.1.e001800.51","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0517-1"},{"key":"2025083110043994000_10.1.e001800.52","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201301-0079OC"},{"key":"2025083110043994000_10.1.e001800.53","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-534","article-title":"Validation of Sputum gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study","volume":"14","author":"Fukuyama","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2025083110043994000_10.1.e001800.54","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.53.2499","article-title":"Importance of functional assessment in the management of community-acquired and healthcare-associated pneumonia","volume":"53","author":"Kosai","year":"2014","journal-title":"Intern Med"},{"key":"2025083110043994000_10.1.e001800.55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.11622\/smedj.2014082","article-title":"I-ROAD could be efficient in predicting severity of community-acquired pneumonia or healthcare-associated pneumonia","volume":"55","author":"Matsunuma","year":"2014","journal-title":"Singapore Med J"},{"key":"2025083110043994000_10.1.e001800.56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ggi.12110","article-title":"Comparison of clinical profile in elderly patients with nursing and healthcare-associated pneumonia, and those with community-acquired pneumonia","volume":"14","author":"Nakagawa","year":"2014","journal-title":"Geriatr Gerontol Int"},{"key":"2025083110043994000_10.1.e001800.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2013.08.006"},{"key":"2025083110043994000_10.1.e001800.58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7883\/yoken.67.269","article-title":"High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance","volume":"67","author":"Takaki","year":"2014","journal-title":"Jpn J Infect Dis"},{"key":"2025083110043994000_10.1.e001800.59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jiac.2013.09.005","article-title":"Serial Quantification of Procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP)","volume":"20","author":"Tamura","year":"2014","journal-title":"J Infect Chemother"},{"key":"2025083110043994000_10.1.e001800.60","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02807"},{"key":"2025083110043994000_10.1.e001800.61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ajem.2014.10.046","article-title":"The impact of age on outcomes of elderly ED patients ventilated due to community acquired pneumonia","volume":"33","author":"Hifumi","year":"2015","journal-title":"Am J Emerg Med"},{"key":"2025083110043994000_10.1.e001800.62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jiac.2015.05.002","article-title":"Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia","volume":"21","author":"Kamata","year":"2015","journal-title":"J Infect Chemother"},{"key":"2025083110043994000_10.1.e001800.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2014.11.006"},{"key":"2025083110043994000_10.1.e001800.64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2169\/internalmedicine.55.5556","article-title":"Computed tomography for the diagnosis and evaluation of the severity of community-acquired pneumonia in the elderly","volume":"55","author":"Haga","year":"2016","journal-title":"Intern Med"},{"key":"2025083110043994000_10.1.e001800.65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5588\/ijtld.15.0353","article-title":"Polybacterial aetiology and outcomes in patients with community-acquired pneumonia","volume":"20","author":"Kumagai","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110043994000_10.1.e001800.66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.resinv.2016.01.001","article-title":"Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia","volume":"54","author":"Kurai","year":"2016","journal-title":"Respir Investig"},{"key":"2025083110043994000_10.1.e001800.67","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jiac.2017.03.018","article-title":"Etiological analysis and epidemiological comparison among adult CAP and NHCAP patients in Okinawa, Japan","volume":"23","author":"Parrott","year":"2017","journal-title":"J Infect Chemother"},{"key":"2025083110043994000_10.1.e001800.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.04.020"},{"key":"2025083110043994000_10.1.e001800.69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijid.2020.01.018","article-title":"The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: a multicentre, prospective study","volume":"92","author":"Ito","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025083110043994000_10.1.e001800.70","first-page":"255","article-title":"Phase III double-blind comparative study of intravenous lascufloxacin and levofloxacin in patients with community-acquired pneumonia","volume":"69","author":"Miki","year":"2021","journal-title":"Jpn J Chemother"},{"key":"2025083110043994000_10.1.e001800.71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051307","article-title":"Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a Multicentre, retrospective observational study","volume":"12","author":"Chen","year":"2022","journal-title":"BMJ Open"},{"key":"2025083110043994000_10.1.e001800.72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12092-w","article-title":"Factors associated with gravity-dependent distribution on chest CT in elderly patients with community-acquired pneumonia: a retrospective observational study","volume":"12","author":"Komiya","year":"2022","journal-title":"Sci Rep"},{"key":"2025083110043994000_10.1.e001800.73","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10096-020-03870-3","article-title":"Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study","volume":"39","author":"Carugati","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025083110043994000_10.1.e001800.74","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1060028020935106","article-title":"Risk factor evaluation for methicillin-resistant staphylococcus aureus and pseudomonas aeruginosa in community-acquired pneumonia","volume":"55","author":"Lewis","year":"2021","journal-title":"Ann Pharmacother"},{"key":"2025083110043994000_10.1.e001800.75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075171","article-title":"Epidemiology and outcome of pneumonia caused by methicillin-resistant staphylococcus aureus (MRSA) in Canadian hospitals","volume":"8","author":"Tadros","year":"2013","journal-title":"PLoS One"},{"key":"2025083110043994000_10.1.e001800.76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245"},{"key":"2025083110043994000_10.1.e001800.77","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix549"},{"key":"2025083110043994000_10.1.e001800.78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jiac.2019.12.011","article-title":"The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009-2018","volume":"26","author":"Naito","year":"2020","journal-title":"J Infect Chemother"},{"key":"2025083110043994000_10.1.e001800.79","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw300"},{"key":"2025083110043994000_10.1.e001800.80","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jiac.2020.05.006","article-title":"Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2016: general view of the pathogens' antibacterial susceptibility","volume":"26","author":"Yanagihara","year":"2020","journal-title":"J Infect Chemother"},{"key":"2025083110043994000_10.1.e001800.81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146520","article-title":"Estimated number of patients with influenza A(H1)Pdm09, or other viral types, from 2010 to 2014 in Japan","volume":"11","author":"Murakami","year":"2016","journal-title":"PLoS One"},{"key":"2025083110043994000_10.1.e001800.82","unstructured":"Ministry of Health . Number of persons receiving routine immunizations. 2023. Available: https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html [Accessed 23 Jul 2023]."},{"key":"2025083110043994000_10.1.e001800.83","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62449-1"},{"key":"2025083110043994000_10.1.e001800.84","doi-asserted-by":"publisher","DOI":"10.1086\/648678"},{"key":"2025083110043994000_10.1.e001800.85","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.075077"},{"key":"2025083110043994000_10.1.e001800.86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/135965350601100306","article-title":"The role of viruses in the aetiology of community-acquired pneumonia in adults","volume":"11","author":"Angeles Marcos","year":"2006","journal-title":"Antivir Ther"},{"key":"2025083110043994000_10.1.e001800.87","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00128-20","article-title":"Multicenter evaluation of the biofire filmarray pneumonia\/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection","volume":"58","author":"Murphy","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2025083110043994000_10.1.e001800.88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-2600(14)70028-1","article-title":"Towards an Ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis","volume":"2","author":"Dickson","year":"2014","journal-title":"The Lancet Respiratory Medicine"},{"key":"2025083110043994000_10.1.e001800.89","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02086-2016","article-title":"The microbiome in respiratory medicine: current challenges and future perspectives","volume":"49","author":"Faner","year":"2017","journal-title":"Eur Respir J"},{"key":"2025083110043994000_10.1.e001800.90","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30721-4"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-001800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:04:51Z","timestamp":1756659891000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-001800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,9,26]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjresp-2023-001800"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-001800","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}